-
No significant drug−drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study
Hiransuthikul, A., Thammajaruk, N., Kerr, S., Janamnuaysook, R., Nonenoy, S., Hongchookiat, P., Trichavaroj, R., Tawon, Y., Boonruang, J., Teeratakulpisarn, N., Cressey, T. R. & the iFACT3 study team, 1 May 2025, In: Journal of the international aids society. 28, 5, e26502.Research output: Contribution to journal › Article* › Academic › peer-review
-
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre-exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open-label pharmacokinetic study in Thailand
Hiransuthikul, A., Thammajaruk, N., Kerr, S., Janamnuaysook, R., Nonenoy, S., Hongchookiat, P., Trichavaroj, R., Tawon, Y., Boonruang, J., Teeratakulpisarn, N., Cressey, T. R. & the iMACT study team, 1 Apr 2025, In: Journal of the international aids society. 28, 4, e26445.Research output: Contribution to journal › Article* › Academic › peer-review
-
Comprehensive Analysis and Leveraging Online Innovations to Improve HIV and STI Prevention and Treatment Services in Major Cities of Thailand
Phiphatkunarnon, P., Phanuphak, N., Janamnuaysook, R., Tran, D., Neo, B.-L. & Tepsan, W., 2025, (E-pub ahead of print) In: AIDS and behavior.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
